DDS4.0 Trademark

Trademark Overview

On Wednesday, March 14, 2018, a trademark application was filed for DDS4.0 with the United States Patent and Trademark Office. The USPTO has given the DDS4.0 trademark a serial number of 79233178. The federal status of this trademark filing is REGISTERED as of Tuesday, May 21, 2019. This trademark is owned by MDimune Inc.. The DDS4.0 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of technology for biotechnology; biotechnological research; development of biologics; product development; chemical research

General Information

Serial Number79233178
Word MarkDDS4.0
Filing DateWednesday, March 14, 2018
Status700 - REGISTERED
Status DateTuesday, May 21, 2019
Registration Number5753938
Registration DateTuesday, May 21, 2019
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 5, 2019

Trademark Statements

Indication of Colors claimedThe color(s) blue-green is/are claimed as a feature of the mark.
Description of the Colors ClaimedThe color blue-green is claimed as a feature of the mark.
Description of MarkThe mark consists of Letters "DDS4.0" in blue-green with horizontal lines in the letters.
Goods and ServicesResearch and development of technology for biotechnology; biotechnological research; development of biologics; product development; chemical research
Pseudo MarkDDS FOUR.ZERO

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 7, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMDimune Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR
Party NameMDimune Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR
Party NameMDimune Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events

Event DateEvent Description
Friday, September 3, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 27, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, September 11, 2019FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, September 11, 2019FINAL DISPOSITION PROCESSED
Wednesday, August 21, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 21, 2019REGISTERED-PRINCIPAL REGISTER
Monday, April 29, 2019LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, April 12, 2019LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, March 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2019PUBLISHED FOR OPPOSITION
Saturday, March 2, 2019NOTIFICATION PROCESSED BY IB
Wednesday, February 13, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 13, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 30, 2019ASSIGNED TO LIE
Tuesday, January 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 10, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 27, 2018REFUSAL PROCESSED BY IB
Wednesday, July 11, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, July 11, 2018REFUSAL PROCESSED BY MPU
Wednesday, June 27, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 26, 2018NON-FINAL ACTION WRITTEN
Monday, June 25, 2018ASSIGNED TO EXAMINER
Tuesday, June 12, 2018APPLICATION FILING RECEIPT MAILED
Thursday, June 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 31, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

research development product chemical biologics biotechnology technology biotechnological